Skip to content

Comparison of the effect of two different types of drugs when mixed to the local anaesthetics for upper limb block

A comparative study of the effect of Dexmedetomidine and Nalbuphine as an adjuvant to Levobupivacaine in ultrasound guided supraclavicular brachial plexus block: A prospective randomized, double blind study

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/05/025082
Enrollment
70
Registered
2020-05-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M00-M99- Diseases of the musculoskeletal system and connective tissue

Interventions

Intervention1: Effect of Nalbuphine as an adjuvant to Levobupivacaine in ultrasound guided supraclavicular brachial plexus block: Another group will receive 20 ml of 0.5% levobupivacaine with 1ml(10mg

Sponsors

Jyoti Mala
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients posted for upper limb surgery of either side 2. Patients of ASA physical status 1 & 2 3. Patients between 18-50 years of age of either sex 4. Patients able to comprehend and willing to participate

Exclusion criteria

Exclusion criteria: 1. Patientâ??s refusal to participate 2. Patients of ASA physical status3 & 4 3. Any allergy to local anaesthetics 4. Coagulation disorders 5. Infection at the site of intervention 6. History of any underlying cardiac, renal or hepatic dysfunction •Pregnant patient

Design outcomes

Primary

MeasureTime frame
1. Onset of motor block 2. Onset of sensory block 3. Duration of analgesia Timepoint: 3 months

Secondary

MeasureTime frame
1. Hemodynamic stability 2. Side effects Timepoint: 3 months

Countries

India

Contacts

Public ContactJyoti Mala

INDIRA GANDHI INSTITUTE OF MEDICAL COLLEGE

drmalajyoti17@gmail.com9955882635

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026